ATE251640T1 - Neues chondrozytprotein - Google Patents

Neues chondrozytprotein

Info

Publication number
ATE251640T1
ATE251640T1 AT94111218T AT94111218T ATE251640T1 AT E251640 T1 ATE251640 T1 AT E251640T1 AT 94111218 T AT94111218 T AT 94111218T AT 94111218 T AT94111218 T AT 94111218T AT E251640 T1 ATE251640 T1 AT E251640T1
Authority
AT
Austria
Prior art keywords
chondrocytes
protein
cartilaginous
control
found
Prior art date
Application number
AT94111218T
Other languages
English (en)
Inventor
Yukio Kato
Haiou Pan
Kazuyuki Doi
Original Assignee
Kato Yukio Prof
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kato Yukio Prof filed Critical Kato Yukio Prof
Application granted granted Critical
Publication of ATE251640T1 publication Critical patent/ATE251640T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT94111218T 1993-07-23 1994-07-19 Neues chondrozytprotein ATE251640T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18233893 1993-07-23

Publications (1)

Publication Number Publication Date
ATE251640T1 true ATE251640T1 (de) 2003-10-15

Family

ID=16116566

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94111218T ATE251640T1 (de) 1993-07-23 1994-07-19 Neues chondrozytprotein

Country Status (7)

Country Link
US (1) US5607920A (de)
EP (1) EP0635518B1 (de)
KR (1) KR950003312A (de)
AT (1) ATE251640T1 (de)
AU (1) AU687407B2 (de)
CA (1) CA2128647A1 (de)
DE (1) DE69433221T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858689A (en) * 1993-07-22 1999-01-12 Ludwig Institute For Cancer Research Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof
US6008013A (en) * 1996-07-05 1999-12-28 University Of Rochester Chondrocyte proteins
WO2000073417A1 (en) * 1999-05-27 2000-12-07 The Research Foundation Of State University Of New York In vitro cell culture device including cartilage and methods of using the same
AU6597700A (en) * 1999-08-19 2001-03-19 Chugai Seiyaku Kabushiki Kaisha Chondrogenesis promoters
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
JPH05178896A (ja) * 1990-08-23 1993-07-20 Mitsubishi Kasei Corp 新規なタンパク質、それをコードする遺伝子及びその産生方法

Also Published As

Publication number Publication date
KR950003312A (ko) 1995-02-16
AU6860294A (en) 1995-02-02
DE69433221T2 (de) 2004-07-29
US5607920A (en) 1997-03-04
CA2128647A1 (en) 1995-01-24
AU687407B2 (en) 1998-02-26
EP0635518B1 (de) 2003-10-08
EP0635518A1 (de) 1995-01-25
DE69433221D1 (de) 2003-11-13

Similar Documents

Publication Publication Date Title
BR1100321A (pt) Polipetìdeo utilizável como elemento de imunogenia, agente imunogênio, composição útil para a prevenção e/ou para o tratamento das afecções provocadas pelo vrs, sequência nucleotìdica, processo de pre uma proteìna
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
ES2160704T3 (es) Tratamiento del sindrome de insensibilidad parcial a la hormona de crecimiento.
CA2259163A1 (en) Nt-3 and bdnf analogs having improved circulating life and/or absorption
NO20050998D0 (no) DNA som koder for et biologisk aktivt fragment av baktericid/premeabilitetsokende protein fremgangsmate for fremstilling av dette, samt farmasoytisk preparat inneholdende dette
IL136076A0 (en) Mammalian cytokin-like polypeptide -10
MY102806A (en) Human interleukin-3 and muteins thereof
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
ATE127844T1 (de) Dns und ihre verwendung.
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
DE69429365D1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
HU895788D0 (en) Process for producing peptides and medical products containing them
PH27403A (en) Polypeptides useful as lockers of calcium channel
DE69433221D1 (de) Neues Chondrozytprotein
EP0515434A4 (en) Method for treating intestinal diseases
ATE366310T1 (de) Menschliches chondromodulin-i-protein
ES2012128A6 (es) Metodo de tratar plantas con acidos organicos que contienen azufre.
DK0914148T3 (da) Behandling af partielt væksthormonoverfølsomhedssyndrom
DE69306273D1 (de) Mitogen für die glatte Muskulatur und dessen kodierende DNS
PT99850A (pt) Processo para a preparacao de novos peptideos com efeito insulinico
ATE85893T1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
ES2129022T3 (es) Proteina condromodulina-i.
JPS5775960A (en) Purified polypeptide
MX9800686A (es) Nueva proteina hmw humana mp52s.
EP0903147A3 (de) Verwendung eines REG-2 als Mitogene für Schwannzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties